<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html dir="ltr" xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml">
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>

<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<!-- 
	This website is powered by TYPO3 - inspiring people to share!
	TYPO3 is a free open source Content Management Framework initially created by Kasper Skaarhoj and licensed under GNU/GPL.
	TYPO3 is copyright 1998-2015 of Kasper Skaarhoj. Extensions are copyright of their respective owners.
	Information and contribution at http://typo3.org/
-->



<title>INHN: Donald F. Klein’s comment on collated (November 17, 2016) document</title>
<meta name="generator" content="TYPO3 4.5 CMS" />

<link rel="stylesheet" type="text/css" href="IMAGES/STYLESHEET_9B1E31873F2366.CSS?1645000983" media="all" />



<script src="IMAGES/JAVASCRIPT_93077BB238F3E1.JS?1645000982" type="text/javascript"></script>


<link href="IMAGES/LAYOUT_3COL_STANDARD.CSS" rel="stylesheet" type="text/css" /><!--[if lte IE 7]><link href="fileadmin/styles/patches/../01_layouts_basics/css/patches/patch_3col_standard.css" rel="stylesheet" type="text/css" /><![endif]-->
<meta name="DC.title" content="Donald F. Klein’s comment on collated (November 17, 2016) document" />
<meta name="description" content="INHN" />
<meta name="DC.Description" content="INHN" />
<meta name="keywords" content="International Network for the History of Neuropsychopharmacology" />
<meta name="DC.Subject" content="International Network for the History of Neuropsychopharmacology" />
<meta name="copyright" content="Copyright INHN 2012-14" />
<meta name="DC.Rights" content="Copyright INHN 2012-14" />
<meta http-equiv="content-language" content="en" />
<meta name="DC.Language" scheme="NISOZ39.50" content="en" />
<link rev="made" href="mailto:inhn@inhn.org" />
<meta http-equiv="reply-to" content="inhn@inhn.org" />
<meta name="author" content="Gregers Wegener" />
<meta name="DC.Creator" content="Gregers Wegener" />
<meta name="rating" content="General" />
<meta name="date" content="2017-01-17T16:39:13+00:00" />
<meta name="DC.date" content="2017-01-17T16:39:13+00:00" />
<meta name="robots" content="index,follow" />
<meta name="revisit-after" content="7" />
<link rel="start" href="INDEX681A.HTM?id=1" />
<link rel="up" href="INDEXD39F.HTM?id=1665" />
<link rel="next" href="INDEX8664.HTM?id=1936" />
<link rel="prev" href="INDEXDF74_2.HTM?id=1836" />
<link rel="canonical" href="INDEX6187.HTM?id=1866" />



</head>
<body id="pageUID-1866">


<div id="page_margins">
	<div id="page">
		<div id="header"><div class="tx-macinasearchbox-pi1">
		
<form action="https://inhn.org/index.php?id=5&amp;L=0" method="post" name="searchform" id="searchform">
<input name="tx_indexedsearch[sword]" type="text" value="Enter search word..." onclick="this.value=''" onblur="this.value='Enter search word...'" /><br />
<input type="hidden" name="tx_indexedsearch[_sections]" value="0" />
<input type="hidden" name="tx_indexedsearch[pointer]" value="0" />
<input type="hidden" name="tx_indexedsearch[ext]" value="0" />
<input type="hidden" name="tx_indexedsearch[lang]" value="0" />
</form>

	</div>
	<div id="topnav"><a class="skip" href="#navigation" title="Direkt zur Navigation springen">Zur Navigation springen</a><span class="hideme">.</span><a class="skip" href="#content" title="Direkt zum Content springen">Zum Content springen</a><span class="hideme">.</span><a href="INDEX3A9F.HTM?id=6" target="_self">Sitemap</a>&nbsp;&#124;&nbsp;<a href="INDEXD61C.HTM?id=5" target="_self">Search</a>&nbsp;&#124;&nbsp;<a href="INDEX65E4.HTM?id=kontakt" target="_self">Contact</a>&nbsp;&#124;&nbsp;<a href="INDEXB7B8.HTM?id=204" target="_self">About INHN</a></div><a href="INDEX2999.HTM?id=202"><img class="headImg1" src="IMAGES/COMPANY_LOGO.GIF" alt="" title="Home" width="598" height="100" /></a></div>
		<div id="nav"><a id="navigation" name="navigation"></a><div id="nav_main" class="hlist"><ul><li><a href="INDEX2999.HTM?id=202" target="_self"><span>Home</span></a></li><li><a href="INDEX7EFD.HTM?id=479" target="_self"><span>Dictionary</span></a></li><li><a href="INDEX3E5C.HTM?id=374" target="_self"><span>Drugs</span></a></li><li><a href="INDEXDBB1.HTM?id=565" target="_self"><span>Photos</span></a></li><li><a href="INDEXD919.HTM?id=342" target="_self"><span>Profiles</span></a></li><li id="current"><a href="INDEXAF9F.HTM?id=355" target="_self"><span>Controversies</span></a></li><li><a href="INDEXD122.HTM?id=641" target="_self"><span>Discoveries</span></a></li><li><a href="INDEX1F24.HTM?id=384" target="_self"><span>Books</span></a></li><li><a href="INDEX3958.HTM?id=467" target="_self"><span>Biographies</span></a></li><li><a href="INDEX677F.HTM?id=642" target="_self"><span>Perspectives</span></a></li><li><a href="INDEX8C00.HTM?id=343" target="_self"><span>Archives</span></a></li><li><a href="INDEX06CB.HTM?id=368" target="_self"><span>Ebooks</span></a></li><li><a href="INDEXA1F1.HTM?id=1755" target="_self"><span>Collated</span></a></li><li><a href="INDEXDF25.HTM?id=4128" target="_self"><span>Multilingual Project</span></a></li><li><a href="INDEXABE4.HTM?id=3884" target="_self"><span>INHN Publisher</span></a></li></ul></div></div>
		<div id="main">
			<div id="teaser" class="clearfix"><div class="rootline">You are here: <a href="INDEXAF9F.HTM?id=355" target="_self">Controversies</a>&nbsp;/&nbsp;<a href="INDEXD39F.HTM?id=1665" target="_self">Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry</a>&nbsp;/&nbsp;Donald F. Klein’s comment on collated (November 17, 2016) document</div><div class="langMenu"><div class="tx-srlanguagemenu-pi1">
		
	</div>
	</div></div>
			<div id="col1">
				<div id="col1_content" class="clearfix">
					<ul id="submenu"><li id="title">Controversies</li><li><a href="INDEX01FF.HTM?id=3395" target="_self">Jay D. Amsterdam and Leemon B. McHenry: The Paroxetine 352 Bipolar Study Revisited: Deconstruction of Corporate and Academic Misconduct.</a><span class="hidden">.</span></li><li><a href="INDEXC230.HTM?id=486" target="_self">Thomas A. Ban: Conflict of interest in neuropsychopharmacology</a><span class="hidden">.</span></li><li><a href="INDEX2AF5.HTM?id=1342" target="_self">Thomas A. Ban: Development of our Vocabulary</a></li><li><a href="INDEX1BE7.HTM?id=3220" target="_self">Thomas A. Ban:  Education in Biological Psychiatry – Homage to Dr. Heinz E. Lehmann</a></li><li><a href="INDEXFB00.HTM?id=829" target="_self">Barry Blackwell: Adumbration; A history lesson</a><span class="hidden">.</span></li><li><a href="INDEX7196.HTM?id=3970" target="_self">Barry Blackwell: A Tale of Two Pioneers.</a></li><li><a href="INDEXD39F.HTM?id=1665" target="_self">Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry</a><span class="hidden">.</span><ul><li><a href="INDEX2BB8.HTM?id=1675" target="_self">Jay D. Amsterdam, Leemon B. McHenry and Jon N. Jureidini’s commentary: Industry-Corrupted Psychiatric Trials</a><span class="hidden">.</span></li><li><a href="INDEX6CE8.HTM?id=1678" target="_self">Hector Warnes’ comment</a><span class="hidden">.</span></li><li><a href="INDEX732A.HTM?id=1710" target="_self">Donald F. Klein’s comment</a><span class="hidden">.</span></li><li><a href="INDEXDF80.HTM?id=1720" target="_self">Mark Kramer’s comment</a><span class="hidden">.</span></li><li><a href="INDEX012D.HTM?id=1793" target="_self">Samuel Gershon’s question</a></li><li><a href="INDEXE810.HTM?id=1809" target="_self">John M. Nardo’s comment</a><span class="hidden">.</span></li><li><a href="INDEXDF74_2.HTM?id=1836" target="_self">Samuel Gershon’s comment</a></li><li><strong>Donald F. Klein’s comment on collated (November 17, 2016) document</strong></li><li><a href="INDEX8664.HTM?id=1936" target="_self">Samuel Gershon’s comment -2</a></li><li><a href="INDEX83F3.HTM?id=1955" target="_self">Charles M. Beasley’s commentary</a><span class="hidden">.</span></li><li><a href="INDEX32DC.HTM?id=2104" target="_self">Barry Blackwell: Corporate corruption follow up</a></li><li><a href="INDEX14A6.HTM?id=2350" target="_self">Charles J. Beasley, Jr’s response to Barry Blackwell’s reply</a></li><li><a href="INDEX77C0.HTM?id=2957" target="_self">Barry Blackwell’s response 2 to Charles M. Beasley’s response 2</a></li><li><a href="INDEX0ACF.HTM?id=2468" target="_self">Jay Amsterdam’s comment on Charles Beasley’s response to Barry Blackwell’s reply to his comment</a></li><li><a href="INDEX9494.HTM?id=2613" target="_self">Charles Beasley’s reply to Jay Amsterdam’s comment on Beasley’s response to Barry Blackwell’s reply to his comment</a></li></ul></li><li><a href="INDEXF833.HTM?id=1944" target="_self">Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry. Revised</a><span class="hidden">.</span></li><li><a href="INDEX8B56.HTM?id=778" target="_self">Barry Blackwell: The anxiety enigma</a><span class="hidden">.</span></li><li><a href="INDEX8B7A.HTM?id=2096" target="_self">Barry Blackwell: The Baby and The Bath Water</a><span class="hidden">.</span></li><li><a href="INDEX07C2.HTM?id=622" target="_self">Barry Blackwell: The lithium controversy: A historical autopsy</a><span class="hidden">.</span></li><li><a href="INDEX12D3.HTM?id=1369" target="_self">Pierre Baumann and Francois Ferrero: An official inqury of the clinical research activities (1946-1972) of Roland Kuhn (1912-2005)</a><span class="hidden">.</span></li><li><a href="INDEXA7C8.HTM?id=2954" target="_self">John Court: A note on the history of Anorexia Nervosa</a></li><li><a href="INDEX32F0.HTM?id=421" target="_self">Paul Devenyi: Addictions are not treatable diseases</a><span class="hidden">.</span></li><li><a href="INDEXE29D.HTM?id=477" target="_self">Paul Devenyi: Pharmacotherapy of addictions</a></li><li><a href="INDEXC591.HTM?id=3315" target="_self">Camille Drach Hojaij: Stein and Empathic Fulfilment.</a><span class="hidden">.</span></li><li><a href="INDEX3CB5.HTM?id=2526" target="_self">François Ferrero: Inquiry of the Geneva 1980s’ Psychiatry Crisis</a><span class="hidden">.</span></li><li><a href="INDEXC947.HTM?id=3727" target="_self">Max Fink: Reconceptualization of Catatonia.</a><span class="hidden">.</span></li><li><a href="INDEX3D6D.HTM?id=2322" target="_self">Ernst J. Franzek: From the dichotomy to a three-part grouping of endogenous psychoses</a><span class="hidden">.</span></li><li><a href="INDEX031F.HTM?id=3472" target="_self">Samuel Gershon: Brintellix  -  votioxetine</a></li><li><a href="INDEXCD60.HTM?id=3191" target="_self">Samuel Gershon: Device for naltrexone delivery</a></li><li><a href="INDEX8E42.HTM?id=3064" target="_self">Samuel Gershon: Ketamine, the “new” breakthrough in the treatment of depression</a><span class="hidden">.</span></li><li><a href="INDEX1823.HTM?id=2488" target="_self">Samuel Gershon: Lithium history</a><span class="hidden">.</span></li><li><a href="INDEX5D83.HTM?id=3646" target="_self">Samuel Gershon: The emergence of “new” drugs in recent years.</a></li><li><a href="INDEXFA6F.HTM?id=3375" target="_self">Samuel Gershon: The Tacrine paradigm.</a><span class="hidden">.</span></li><li><a href="INDEXF3E3.HTM?id=670" target="_self">Samuel Gershon: The trazodone cntrovery and its potential fatal consequences</a></li><li><a href="INDEX4A93.HTM?id=2894" target="_self">Ken Gillman: Medical science publishing: A slow-motion train wreck</a><span class="hidden">.</span></li><li><a href="INDEXDBE8.HTM?id=3720" target="_self">David Healy: Do Randomized Controlled Trials Add to or Subtract from Clinical Knowledge?</a><span class="hidden">.</span></li><li><a href="INDEX3202.HTM?id=1350" target="_self">David Healy: The shipwreck of the singular</a><span class="hidden">.</span></li><li><a href="INDEX2555.HTM?id=2447" target="_self">Hanfried Helmchen: The role of psychopharmacotherapy in the early development of social psychiatry in Germany</a><span class="hidden">.</span></li><li><a href="INDEXE41A.HTM?id=2095" target="_self">Carlos R. Hojaij: A Psychopathological Marker For Biological Psychiatry:  The Point of No Return and the “Something New&quot; *</a></li><li><a href="INDEX4C30.HTM?id=1823" target="_self">Carlos R. Hojaij: “DSM-5: The Future of Psychiatric Diagnosis” or Continuing the Psychiatry DiSMantlement</a><span class="hidden">.</span></li><li><a href="INDEX14F7.HTM?id=2103" target="_self">Carlos R. Hojaij: Psychiatry and Medicine</a></li><li><a href="INDEX711C.HTM?id=2118" target="_self">Carlos R. Hojaij: Towards a Psychiatric Biology</a></li><li><a href="INDEX61B8.HTM?id=3147" target="_self">David Janowsky: Cholinergic muscarinic mechanisms in depression and mania</a><span class="hidden">.</span></li><li><a href="INDEXC12C.HTM?id=3956" target="_self">Daniel Kanofsky and Mary E. Woesner: A Fresh Air Approach to COVID-19.</a><span class="hidden">.</span></li><li><a href="INDEX0B8F.HTM?id=530" target="_self">Martin M. Katz: Component-Specific vs. Diagnosis-Specific Clinical Trial in Depression</a><span class="hidden">.</span></li><li><a href="INDEXBDA3.HTM?id=594" target="_self">Martin M. Katz: Multivantaged vs. conventional assessment method</a><span class="hidden">.</span></li><li><a href="INDEX46C5.HTM?id=496" target="_self">Martin M. Katz: Onset of clinical action of antidepressants</a><span class="hidden">.</span></li><li><a href="INDEX94E9.HTM?id=1147" target="_self">Martin  M. Katz: The need and rationale for shortenng the clinical trial for antidepressants</a></li><li><a href="INDEXB724.HTM?id=2329" target="_self">Donald F. Klein, Max Fink, Edward Shorter and Thomas A. Ban: Comment exchange on Flagrant Catatonic Behavior.</a><span class="hidden">.</span></li><li><a href="INDEXA16A.HTM?id=1625" target="_self">Joseph Knoll: Controversies on selegiline/(-)-deprenyl’s  pharmacological spectrum after more than 50 years of its development</a></li><li><a href="INDEX98B4.HTM?id=2771" target="_self">Magda Malewska-Kasprzak, Agnieszka Permoda-Osip, Janusz Rybakowski:Disturbances of the purinergic system in affective disorders and schizophrenia</a><span class="hidden">.</span></li><li><a href="INDEXBB29.HTM?id=4134" target="_self">Trudo Lemmens. “Medical Assistance in Dying” (Euthanasia and Assisted Suicide) in Canada: A Case Raises Questions About Its Use in Patients with Disability and Mental Illness.</a><span class="hidden">.</span></li><li><a href="INDEXEBA9.HTM?id=3891" target="_self">Amy S. F. Lutz: The Rise and Fall of the Dexamethasone Suppression Test: Stability, Consensus, Closure.</a><span class="hidden">.</span></li><li><a href="INDEX41D4.HTM?id=3252" target="_self">Gin S. Malhi: A critical analysis of concepts in psychiatry</a><span class="hidden">.</span></li><li><a href="INDEXD25B.HTM?id=2701" target="_self">Antonio E. Nardi, Richard Balon, Guy Chouinard, Fiammetta Cosci, Steven Dubovsky, Giovanni A. Fava, Rafael C. Freire, David J. Greenblatt, John H. Krystal, Karl Rickels, Thomas Roth, Carl Salzman, Richard I. Shader, Edward K. Silberman, Nicoletta Sonino,</a><span class="hidden">.</span></li><li><a href="INDEX4CFC.HTM?id=2972" target="_self">János Radó: Renal Toxicity of Lithium in Historical Perspective with Special Reference To Nephrogenic Diabetes Insipidus and its Treatment</a><span class="hidden">.</span></li><li><a href="INDEXD26F.HTM?id=3140" target="_self">Janos Radó: Desmopressin may counteract polyuria in lithium-induced nephrogenic diabetes insipidus. Review of the literature</a><span class="hidden">.</span></li><li><a href="INDEX13F5.HTM?id=1248" target="_self">Shridhar Sharma: Insulin coma treatment: Facts and controversies</a><span class="hidden">.</span></li><li><a href="INDEX5461.HTM?id=390" target="_self">Edward Shorter: The Q-T interval and the Mellaril story - a cautionary tale</a><span class="hidden">.</span></li><li><a href="INDEX70B9.HTM?id=2755" target="_self">Leonardo Tondo: Brief History of Suicide in Western Cultures</a><span class="hidden">.</span></li><li><a href="INDEX7938.HTM?id=2000" target="_self">Hector Warnes: The gut-brain axis</a><span class="hidden">.</span></li><li><a href="INDEXEABE.HTM?id=3450" target="_self">Hector Warnes: Pyridoxine in the treatment of lithium-induced tremor.</a><span class="hidden">.</span></li></ul>
					
					<div class="textBelowMenu"><!--TYPO3SEARCH_begin--><!--TYPO3SEARCH_end--></div>
				</div>
			</div>
			<div id="col2">
				<div id="col2_content" class="clearfix"><!--TYPO3SEARCH_begin--><!--TYPO3SEARCH_end--></div>
			</div>
			<div id="col3">
			  <a id="content" name="content"></a>
				<div id="col3_content" class="clearfix">
					<div class="floatbox"><!--TYPO3SEARCH_begin--><div id="c3575" class="csc-default"><h1><span style="font-weight: normal;">Barry Blackwell: Corporate corruption in the psychopharmaceutical industry</span></h1>
<h2><b>Donald F. Klein’s comment on collated (November 17, 2016) document</b></h2>
<p>&nbsp;</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Presenting Blackwell's critique of the current psychopharmacological debacle, collated with other expert opinions, offers a very rich menu.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At first, I thought it would be possible to make a detailed analysis of each stated opinion, but soon gave up. My own views are fairly simple, probably more left than most, but I still wish that Barry Blackwell's legislative hopes come true. However, given recent disheartening electoral results, such hopes appear wishful fantasies. It is difficult to arrive at a coherent, hopeful program</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The absolutely central problem seems to be poorly regulated profit seeking. This is made especially difficult in an area that generally has received cultural high respect. Criticizing the work of healing professionals and industrial provision of effective medications appears the work of cranks.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Affecting regulation via legislation seems the way to go, but not now.&nbsp; In the context of a backlash against our current government's continued failure to meet its promises, there may be a possibility.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; However, such a failure does not necessarily lead to improvement. Things might get worse. It is to avoid this dire possibility that despite current defeat, a continued effort is called for, but it needs definition.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Efforts to communicate the positive benefits of scientific efforts are needed. A book like “Microbe Hunter“ inspired a generation.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Negative critiques are also needed, but there is too much to criticize.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Judgment is necessary. Focusing on the public’s vital, personal concerns are most effective. Critiques of issues such as endemic KOLs, medicalizing normality, lying with statistics, conflicts of interests, pervasive corruption, necessary dimensionality, etc., are often handled as inexplicable value deteriorations, abstract conflicts, or unjust exploitations, rather than real dangers to the reader. Tangential critiques that offer nothing but nostalgia, such as “holistic” care, further blur the issues.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; We should learn from the youth uprisings of the 60s. They were due to the draft. Current absence is due to being draft free.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An abstract focus on the corrupting, anti-scientific effects of hiding negative data that causes the destruction of evidence-based medicine bores many.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Greedy motivation and anti-public health effects are easily understood, but rarely arousing. Most important is that your doctor has been deprived of&nbsp; a truthful basis&nbsp; for the best treatment. That is personally arousing because of directly being put in danger. Similarly, that biased papers or downright false presentations mislead your doctor’s practice, strikes home.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Even though a scientific focus on corrupted research causing personal danger may be insufficient to directly gain useful regulation, it should appeal to effective political effort.</p>
<p>&nbsp;</p>
<p>Donald F. Klein</p>
<p>January 19, 2017</p>
<p>&nbsp;</p>
<p>&nbsp;</p></div><!--TYPO3SEARCH_end--></div>
				</div>
				<div id="ie_clearing">&nbsp;</div>
			</div>
		</div>
		<div id="footer">&copy; INHN 2012-2022 ::: INHN Central Office  · Av. Sagrada Familia Esq Nazaret · Córdoba, Córdoba X5000 · Argentina  ::: email: inhn@inhn.org</div>
	</div>
</div>





<script src="IMAGES/URCHIN.JS" type="text/javascript">
</script>
<script type="text/javascript">
_uacct = "UA-39727086-1";
urchinTracker();
</script>
</body>
</html>